Market Newsdesk

SAN MATEO, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”) today announced it will report its financial and operational results for the three months ended September 30, 2020 after markets close on November 23, 2020.

Conference Call Details

At 5:00 pm Eastern Time / 2:00 pm Pacific Time the same day (November 23, 2020) the Company will host a conference call and webcast to discuss the financial results and its recent corporate highlights.

Participant Dial-In Numbers:

Toll-Free: (866) 220-4156

Toll / International: (864) 663-5231

*Participants should request the Plus Products Earnings Call or provide conference ID: 1087279

Please dial-in or log-on to the webcast at least 15 minutes before the start of the call

The call will also be webcast at https://edge.media-server.com/mmc/p/sqg6kpjg

Please visit the website at least 15 minutes prior to the call to register, download, and install any necessary audio software. Following the conclusion of the call, there will be an archived audio webcast of the conference call available for replay on the Company’s website at PlusProductsInc.com.

Jake Heimark, Co-founder and Chief Executive Officer, and Nate Pearson, Chief Financial Officer, will be conducting a question and answer session following the prepared remarks.

About PLUS

PLUS is a cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA.

Fo
r further information contact:

Jake Heimark
CEO & Co-founder
[email protected]

Investors:

Blake Brennan
Investor Relations
[email protected]
Tel +1 213.282.6987

Media:

Mattio Communications
[email protected] 

The CSE does not accept responsibility for the adequacy or accuracy of this release.

WASHINGTON, Nov. 19, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that the firm received the “Special Contribution Award 2020, Outstanding Contribution Award for COVID-19” at the Procurement Success Awards 2020.

The Procurement Success Awards are described as the top-level procurement award ceremony in the Asia Pacific region. FTI Consulting was recognized for its global effort, working directly with the Office of the Mayor of the City of New York and suppliers in China, to deliver personal protective equipment to New York City during the height of the COVID-19 pandemic. The firm helped identify a large pool of suppliers and developed a shortlist of qualified vendors based on product quality, reputation, certification, scalability, price and on-site visits to the facilities.

In addition to the sourcing, logistics and regulatory components, FTI Consulting leveraged its expertise to help expand New York City’s warehouse network. The team refined stockpile targets based on projected needs and daily burn rates and provided ongoing analytics around specific hospital data, vendor performance, market trends, price fluctuations and spend details. By refreshing and reimagining the city’s inventory system, the team ensured that proper equipment was available, identifiable and ultimately delivered to healthcare workers on the frontlines of the COVID-19 pandemic.

Commenting on the award, Bill He, a Senior Managing Director and Leader of the Business Transformation practice in Asia at FTI Consulting, said, “We are pleased that we were able to leverage our logistics and procurement expertise across the global FTI Consulting platform to help deliver the necessary protective equipment to frontline workers as they battled the COVID-19 pandemic.”

About FTI Consulting

FTI Consulting, Inc. is a global business advisory firm dedicated to helping organizations manage change, mitigate risk and resolve disputes: financial, legal, operational, political & regulatory, reputational and transactional. With more than 6,200 employees located in 28 countries, FTI Consulting professionals work closely with clients to anticipate, illuminate and overcome complex business challenges and make the most of opportunities. The Company generated $2.35 billion in revenues during fiscal year 2019. For more information, visit www.fticonsulting.com and connect with us on Twitter (@FTIConsulting), Facebook and LinkedIn.

FTI Consulting, Inc.

555 12^th Street NW
Washington, DC 20004
+1.202.312.9100

Investor
Contact
:

Mollie Hawkes
+1.617.747.1791
[email protected]

Media
Contact
:

Matthew Bashalany
+1.617.897.1545
[email protected]

VANCOUVER, British Columbia, Nov. 19, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a telehealth company revolutionizing the delivery of healthcare to patients, is pleased to announce that it has closed the previously announced acquisition of Re:Function Health Group Inc. (“Re:Function”), a leading rehabilitation clinic network, with 8 clinics and 37 specialists and allied health professionals.

Dr.
Essam Hamza, CEO of CloudMD commented, “We are excited to close the acquisition of Re:Function and have already started working with the entire team. Through strategic M&A, we have acquired a number of already successful standalone healthcare solutions that combined, will create one transformative platform that emphasizes whole-personcare. The integration of these solutions is already very much underway and already showing early beneficial results. I am extremely proud of our team for their diligence and focus in building the solid foundation which has enabledCloudMD to be a leader in the space.”

Re:Function is a state-of-the-art rehabilitation company built by like-minded health professionals offering superior patient focused care, with a longitudinal approach to healthcare delivery. Re:Function provides assessments for enterprise clients, insurers and corporations for long-term disability claims and return to work outcomes. CloudMD will integrate its telemedicine solutions throughout the clinics, layering on additional allied health and specialist functions to the platform. The practice is made up of four key rehabilitation pillars, Re:Build (physiotherapy), Re:Think (counselling), Re:View (medlegal consulting) and Re:Tool (vocational rehabilitation), and a team of specialists including: Occupational Therapists, Physiotherapists, Kinesiologists, Psychologists, Psychiatrists and Counsellors.

The acquisition will be immediately accretive to CloudMD as the Re:Function group of clinics generated approximately $5.8 million in revenues with earnings before interest, taxes, depreciation and amortization (EBITDA) margins exceeding 19% over the last fiscal year ending January, 2020.

Re:Function’s principle Directors, Ralph Cheesman and Mike Smith, both Occupational Therapists, will be joining CloudMD to lead the continued expansion of allied health services across North America, and together will provide a multidisciplinary, team-based approach to treatment.

Terms of
Agreement

In consideration for the purchase of 100% of the outstanding securities of Re:Function, CloudMD has agreed to pay shareholders aggregate consideration of C$8,000,000 payable as follows: (i) C$3,000,000 in cash, subject to a working capital adjustment; (ii) C$3,500,000 in shares of the Company; and (iii) a performance-based earnout of C$1,500,000, which is payable in shares of the Company in annual issuances over a period of three years. All shares issued pursuant to the acquisition are issued at a deemed price of C$0.88 per share and are priced by calculating the ten-day volume weighted average trading price of the Company’s shares for the 10 trading days prior to the execution of the binding term sheet executed on August 21, 2020. The shares will be subject to certain contractual restrictions on trading for a period of thirty months from the date of issuance.

About Re:Function Health Group

Re:Function is a state-of-the-art rehabilitation company built by like-minded health professionals offering superior patient focused care, with a longitudinal approach to healthcare delivery. The practice is made up of four key rehabilitation pillars, Re:Build (physiotherapy), Re:Think (counselling), Re:View (medlegal consulting) and Re:Tool (vocational rehabilitation), and a team of specialists including: Occupational Therapists, Physiotherapists, Kinesiologists, Psychologists, Psychiatrists and Counsellors. For more information visit www.refunction.ca

About CloudMD Software & Services

CloudMD is digitizing the delivery of healthcare by providing a patient centric approach, with an emphasis on continuity of care. The Company offers SAAS based health technology solutions to healthcare providers across North America and has developed proprietary technology that delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, educational resources and artificial intelligence (AI). CloudMD currently services a combined ecosystem of over 500 clinics, almost 4000 licensed practitioners and 8 million patient charts across North America.

ON BEHALF OF THE BOARD OF DIRECTORS

“Dr. Essam Hamza, MD”

Chief Executive Officer

FOR ADDITIONAL INFORMATION CONTACT:

Julia Becker

VP, Investor Relations

[email protected]

Forward Looking Statements

This news release contains forward-looking statements that are based on CloudMD’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business. Although CloudMD believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and CloudMD undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

Non-GAAP
and Non-IFRS
Measures

This press release refers to “EBITDA” and “EBITDA margins” which are non-GAAP and non-IFRS financial measures that do not have a standardized meaning prescribed by GAAP or IFRS. The Company’s presentation of these financial measures may not be comparable to similarly titled measures used by other companies. These financial measures are intended to provide additional information to investors concerning the Company’s and Re:Function’s performance. EBITDA is defined as earnings before interest, taxes, depreciation and amortization and EBITDA margins is defined as EBITDA as a percent of total revenue. EBITDA and EBITDA margins are Non-IFRS measures the Company uses as an indicator of financial health and excludes several items which may be useful in the consideration of the financial condition of the Company and Re:Function, as applicable, including interest expense, income taxes, depreciation, and amortization.

The
TSX Venture
Exchange does not accept responsibility for the adequacy or accuracy of this release.

TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) — Marathon Gold Corporation (“Marathon” or the “Company”;TSX: MOZ) is pleased to report additional drill results from recent exploration drilling at the Valentine Gold Project, central Newfoundland (the “Project”). These latest results represent fire assay data from fifteen drill holes located within the new Berry Zone which were completed as part of the ongoing Berry infill drill program. Highlights include:

• VL-20-8
  89 intersected 3.70 g/t Au over 42 metres including 73.26 g/t Au over 1 metre and 13.48 g/t Au over 1 metre and 11.84 g/t Au over 1 metre and 11.77 g/t Au over 1 metre, and 1.68 g/t Au over 24 metres including 10.66 g/t Au over 1 metre, and 25.74 g/t Au over 1 metre;
• VL-20-8
  86 intersected 1.68 g/t Au over 26 metres including 10.55 g/t Au over 1 metre;
• VL-20-8
  80 intersected 1.47 g/t Au over 30 metres including 10.54 g/t Au over 1 metre;
• VL-20-8
  83 intersected 1.42 g/t Au over 18 metres;
• VL-20-8
  81 intersected 1.42 g/t Au over 13 metres and 1.12 g/t Au over 12 metres;
• VL-20-891 intersected 1.03 g/t Au over 16 metres and 3.82 g/t Au over 5 metres including 11.01 g/t Au over 1 metre;
• VL-20-893 intersected 3.52 g/t Au over 10 metres including 12.54 g/t Au over 1 metre; and,
• VL-20-8
  77 intersected 33.29 g/t Au over 1 metre.

All quoted intersections comprise uncut gold assays in core lengths. All significant assay intervals are reported in Table 1.

Matt Manson, President & CEO commented: “These latest results from the new Berry Zone continue to demonstrate long intersections of Quartz-Tourmaline-Pyrite-Gold mineralization in characteristic “Main Zone” configurations within our in-fill drill area. By the end of this month we expect to have completed our 52,000 metre 2020 exploration drill program at the Valentine Gold project, including the 8,000 metres of infill drilling at Berry. Assay results from this drilling are expected to be released in batches through the end of the year and into January. These will include assay results from Berry, the Sprite Corridor between Berry and the Frozen Ear Pond (FEP) Road, the FEP Road to the Marathon Deposit, and the Narrows area located northeast of the Marathon Deposit. The results of the Berry drilling will then be incorporated in a new Mineral Resource estimate. Given the success of our 2020 exploration drilling, and the scale of mineralization we are seeing at Berry, we anticipate an equally vigorous exploration program in 2021.”

Gold mineralization at the Valentine Gold Project is contained predominantly within shallowly southwest dipping, en-echelon stacked Quartz-Tourmaline-Pyrite-Gold (“QTP-Au”) veins. At the Leprechaun and Marathon Deposits, as well as at the new Berry Zone, these QTP-Au veins form densely stacked and northwest plunging “Main Zone” envelopes within intrusive host rocks on the hanging wall (northwest) side of the Valentine Lake Shear Zone. The extent of mineralization appears related to the size and frequency of sheared mafic dykes which extend northeast-southwest within the hanging wall, parallel to the shear zone. Exploration drilling is generally undertaken in two orientations: down steeply towards the northwest at a high angle to the individual veins and down-plunge of the Main Zone stacking, or obliquely towards the southeast sub-parallel to the individual veins and across the strike of Main Zone mineralization.

The results released today are derived from fourteen drillholes located between sections 13400E and 13650E at the western end of the Berry in-fill area (VL-20-877, 878, 880, 881, 883, 884, 885, 886, 887, 888, 889, 890, 891 and 894), and one hole at section 13970E close to the eastern end (VL-20-893; Figures 2 and 3). All holes were oriented steeply down to the northwest.

Overall, fourteen of the fifteen drill holes returned “significant” drill intersections of greater than 0.7 g/t Au (Table 1). Each of these fourteen holes returned additional intersections with gold grades above the 0.3 g/t Au cut-off used in the January 2020 Mineral Resource Estimate for the Project. No economic mineralization was encountered in drill hole VL-20-878 which stayed within footwall sedimentary rocks.

Technical Investor Session

The Company will be hosting an online technical session focussing on exploration and engineering plans for the Valentine Gold Project on November 24th at 10:00 A.M. EST. A presentation by management will be followed by Q&A. To register, please visit: bit.ly/2IAKeeO

Table 1: Significant assay intervals, Sprite Corridor, Valentine Gold Project

DDH	Section	Az	Dip	From	To	Core Length (m)	True Thickness (m)	Gold g/t	Gold g/t (cut)
VL-20-877	13400	345	-79	16	17	1	0.95	0.76
				58	59	1	0.95	1.74
				95	97	2	1.9	0.79
				125	126	1	0.95	3.00
				130	132	2	1.9	1.27
				135	136	1	0.95	0.87
				143	146	3	2.85	1.26
				150	151	1	0.95	0.83
				153	154	1	0.95	33.29	30
VL-20-880	13430	345	-76	97	98	1	0.95	1.19
				101	102	1	0.95	1.05
				125	126	1	0.95	2.56
				144	174	30	28.5	1.47
including				155	156	1	0.95	10.54
VL-20-881	13450	343	-77	18	28	10	9.5	1.09
				36	38	2	1.9	1.59
				42	43	1	0.95	1.62
				55	56	1	0.95	0.71
				70	71	1	0.95	2.87
				103	116	13	12.35	1.42
				123	125	2	1.9	1.05
				134	146	12	11.4	1.12
				154	163	9	8.55	1.18
				178	179	1	0.95	0.74
				183	185	2	1.9	2.53
				189	190	1	0.95	2.04
VL-20-883	13480	343	-78	28	29	1	0.95	1.36
				82	83	1	0.95	3.11
				97	98	1	0.95	0.92
				104	107	3	2.85	1.20
				137	155	18	17.1	1.42
				176	178	2	1.9	1.39
VL-20-884	13500	347	-79	88	89	1	0.95	3.03
VL-20-885	13480	345	-81	71	73	2	1.9	0.88
				78	79	1	0.95	1.37
				81	82	1	0.95	0.71
				86	88	2	1.9	1.55
				96	97	1	0.95	1.28
				128	129	1	0.95	2.82
				178	180	2	1.9	0.82
VL-20-886	13480	344	-80	97	123	26	24.7	1.68
				120	121	1	0.95	10.55
				128	129	1	0.95	0.76
				86	88	2	1.9	1.55
				96	97	1	0.95	1.28
				128	129	1	0.95	2.82
VL-20-887	13480	337	-78	59	76	17	16.15	0.84
VL-20-888	13540	343	-75	17	18	1	0.95	1.45
				40	41	1	0.95	0.94
VL-20-889	13580	342	-77	11	12	1	0.95	0.89
				15	16	1	0.95	25.74
				21	22	1	0.95	0.85
				37	79	42	39.9	3.70	2.67
including				44	45	1	0.95	11.77
Including				52	53	1	0.95	11.84
Including				71	72	1	0.95	73.26	30
Including				78	79	1	0.95	13.48
				117	123	6	5.7	0.90
				126	127	1	0.95	2.26
				129	130	1	0.95	0.93
				145	146	1	0.95	1.96
				155	179	24	22.8	1.68
Including				156	157	1	0.95	10.66
				204	205	1	0.95	0.85
				209	210	1	0.95	1.73
				251	252	1	0.95	0.97
				268	269	1	0.95	1.21
				280	281	1	0.95	6.43
				297	298	1	0.95	0.74
VL-20-890	13580	342	-76	54	55	1	0.95	0.75
				62	63	1	0.95	15.01
				81	82	1	0.95	1.20
				126	127	1	0.95	4.82
				132	133	1	0.95	4.30
VL-20-891	13630	342	-75	8	10	2	1.9	5.04
				25	26	1	0.95	3.38
				30	34	4	3.8	2.66
				42	43	1	0.95	3.16
				106	107	1	0.95	0.94
				135	136	1	0.95	0.91
				140	156	16	15.2	1.03
				170	174	4	3.8	2.89
				188	189	1	0.95	0.90
				195	200	5	4.75	3.82
Including				199	200	1	0.95	11.01
				253	254	1	0.95	1.62
VL-20-89 3	13970	345	-75	24	25	1	0.95	8.08
				35	36	1	0.95	2.60
				43	44	1	0.95	1.40
				48	51	3	2.85	1.39
				56	66	10	9.5	3.52
Including				61	62	1	0.95	12.54
				93	94	1	0.95	1.13
				102	103	1	0.95	7.17
				107	108	1	0.95	5.84
				124	126	2	1.9	1.35
				221	223	2	1.9	0.76
VL-20-89 4	13650	343	-75	128	129	1	0.95	0.85
				138	139	1	0.95	0.96
				144	145	1	0.95	1.16
				151	152	1	0.95	2.31

Notes on


the Calculation of Assay Intervals

1. “Significant” assay intervals are defined as 1m core length or more of mineralization with an average fire assay result of greater than 0.7 g/t Au, representing the bottom cut-off for high-grade mill feed in the Marathon April 2020 Pre-Feasibility Study mine plan (see technical report dated April 21, 2020). Assay intervals with an average fire assay result of between 0.3 g/t Au and 0.7 g/t Au are above
   the
   cut-off used in the January 2020 Mineral Resource Estimate for the Project but are not considered “significant”
   for the purposes of
   this news release
   .
2. Cut gold grades are calculated at 30 g/t Au.
3. No significant assays were returned in drill hole
   s
   VL-20-
   8
   7
   8
   

Figure 1: Location Map, Valentine Gold Project. (See News Release Dated February 3, 2020 for a Description of the 2020 Exploration Drill Program) is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/45733e0c-754e-4202-9724-b20dc813ebd7

Figure 2: Location of Berry Zone Exploration Drill Hole Collars VL-20-877 to VL-20-894 is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f6979e9c-a717-4958-b48e-5dfa60c74593

Figure 3: Cross section 13580E (View NE) Sprite Corridor, Valentine Gold Project is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cb23a20c-a27d-4314-b9b5-7dac48ea2522

Qualified Person

Disclosure of a scientific or technical nature in this news release was prepared under the supervision of Nicholas Capps, P.Geo. (NL), Project Manager for exploration at the Valentine Gold Project. Exploration data quality assurance and control for Marathon is under the supervision of Jessica Borysenko, P.Geo (NL), GIS Manager for Marathon Gold Corporation. Both Mr. Capps and Ms. Borysenko are qualified persons under National Instrument (“NI”) 43-101.

Quality Assurance-Quality Control (“QA/QC”)

QA/QC protocols followed at the Valentine Gold Project include the insertion of blanks and standards at regular intervals in each sample batch. Drill core is cut in half with one half retained at site, the other half tagged and sent to Eastern Analytical Limited in Springdale, NL. All reported core samples are analyzed for Au by fire assay (30g) with AA finish. All samples above 0.30 g/t Au in economically interesting intervals are further assayed using metallic screen to mitigate the presence of coarse gold. Significant mineralized intervals are reported in Table 1 as core lengths and estimated true thickness (70 – 95% of core length), and reported with and without a top-cut of 30 g/t Au applied.

Acknowledgments

Marathon acknowledges the financial support of the Junior Exploration Assistance Program, Department of Natural Resources, Government of Newfoundland and Labrador.

About Marathon

Marathon (TSX:MOZ) is a Toronto based gold company advancing its 100%-owned Valentine Gold Project located in the central region of Newfoundland and Labrador, one of the top mining jurisdictions in the world. The Project comprises a series of four mineralized deposits along a 20-kilometre system. An April 2020 Pre-Feasibility Study outlined an open pit mining and conventional milling operation over a twelve-year mine life with a 36% after-tax rate of return. The Project has estimated Proven Mineral Reserves of 1.3 Moz (26.3 Mt at 1.52 g/t) and Probable Mineral Reserves of 0.6 Moz (14.8 Mt at 1.23 g/t). Total Measured Mineral Resources (inclusive of the Mineral Reserves) comprise 1.9 Moz (31.7 Mt at 1.86 g/t) with Indicated Mineral Resources (inclusive of the Mineral Reserves) of 1.19 Moz (23.2 Mt at 1.60 g/t). Additional Inferred Mineral Resources are 0.96 Moz (16.77 Mt at 1.78 g/t Au). Please see the Technical Report dated April 21, 2020 for further details and assumptions relating to the Valentine Gold Project.

For more information, please contact:

Matt Manson President & CEO Tel: 416 987-0711 [email protected]

Hannes Portmann CFO & Business Development Tel: 416 855-8200 [email protected]

Amanda Mallough Senior Associate, Investor Relations Tel: 416 855-8202 [email protected]

To find out more information on Marathon Gold Corporation and the Valentine Gold Project, please visit www.marathon-gold.com.

Cautionary Statement Regarding Forward-Looking Information

Certain information contained in this news release, constitutes forward-looking information within the meaning of Canadian securities laws (“forward-looking statements”). All statements in this news release, other than statements of historical fact, which address events, results,
outcomes
or developments that Marathon expects to occur are forward-looking statements. Forward-looking statements include statements that are predictive in nature, depend upon or refer to future events or conditions, or include words such as “expects”, “anticipates”, “plans”, “believes”, “estimates”, “considers”, “intends”, “targets”, or negative versions thereof and other similar expressions, or future or conditional verbs such as “may”, “will”, “should”, “would” and “could”. We provide forward-looking statements for the purpose of conveying information about our current expectations and plans relating to the future, and readers are cautioned that such statements may not be appropriate for other purposes. More particularly and without restriction, this news release contains forward-looking statements and information about Marathon’s intention to complete the Offering and the timing thereof, economic analyses for the Valentine Gold Project, capital and operating costs, processing and recovery estimates and strategies, future exploration and mine plans, objectives and expectations and corporate planning of Marathon, future feasibility studies and environmental impact statements and the timetable for completion and content thereof and statements as to management’s expectations with respect to, among other things, the matters and activities contemplated in this news release.

Forward-looking statements involve known and unknown risks,
uncertainties
and assumptions and accordingly, actual results and future events could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. A mineral resource that is classified as “inferred” or “indicated” has a great amount of uncertainty as to its existence and economic and legal feasibility. It cannot be assumed that any or part of an “indicated mineral resource” or “inferred mineral resource” will ever be upgraded to a higher category of mineral resource. Investors are cautioned not to assume that all or any part of mineral deposits in these categories will ever be converted into proven and probable mineral reserves.

By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. Factors that could cause future results or events to differ materially from current expectations expressed or implied by the forward-looking statements include receipt of all necessary regulatory approvals, completion of all conditions to closing of the Offering, availability of financing to fund Marathon’s exploration and development activities, the ability of the current exploration program to identify and expand mineral resources, operational risks in exploration and development for gold, Marathon’s ability to realize the pre-feasibility study, delays or changes in plans with respect to exploration or development projects or capital expenditures, uncertainty as to calculation of mineral resources, changes in commodity and power prices, changes in interest and currency exchange rates, the ability to attract and retain qualified personnel, inaccurate geological and metallurgical assumptions (including with respect to the size, grade and recoverability of mineral resources), changes in development or mining plans due to changes in logistical, technical or other factors, title defects, government approvals and permits, cost escalation, changes in general economic conditions or conditions in the financial markets, environmental regulation, operating hazards and risks, delays, taxation rules, competition, public health crises such as the COVID-19 pandemic and other uninsurable risks, liquidity risk, share price volatility, dilution and future sales of common shares, aboriginal claims and consultation, cybersecurity threats, climate change, delays and other risks described in Marathon’s documents filed with Canadian securities regulatory authorities.

You can find further information with respect to these and other risks in Marathon’s Amended and Restated Annual Information Form for the year ended December 31, 2019 and other filings made with Canadian securities regulatory authorities available at

www.sedar.com

. Other than as specifically required by law, Marathon undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made, or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results otherwise.

HARRISBURG, Pa., Nov. 19, 2020 (GLOBE NEWSWIRE) — Ollie’s Bargain Outlet Holdings, Inc. (Nasdaq: OLLI) announced today that it will release its financial results for the third quarter of fiscal 2020 on Thursday, December 3, 2020 after the market closes.   Following the release, at 4:30 p.m. Eastern Time the company’s management will host a conference call to discuss its results.

Investors and analysts can participate on the conference call by dialing (800) 219-7052 or (574) 990-1029 and using conference ID #7382297. Interested parties can also listen to a live webcast or replay of the conference call by logging on to the Investor Relations section on the Company’s website at http://investors.ollies.us/.

About Ollie’s

We are a highly differentiated and fast growing, extreme value retailer of brand name merchandise at drastically reduced prices. We are known for our assortment of merchandise offered as Good Stuff Cheap®. We offer name brand products, Real Brands! Real Bargains!®, in every department, including housewares, food, books and stationery, bed and bath, floor coverings, toys, health and beauty aids and other categories. We currently operate 389 stores in 25 states throughout half of the United States. For more information, visit www.ollies.us.

Investor Contact:

Jean Fontana
ICR
646-277-1214
[email protected]

Media Contact:

Tom Kuypers
Senior Vice President – Marketing & Advertising
717-657-2300
[email protected]

LAS VEGAS, NV, Nov. 19, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company”), a global brand management holdings company, is excited to announce that its new Proceso, Pod5ive datacenter pod (the “Pod5”), which is capable of driving Megawatt-level cryptocurrency computational mining power, has been fully assembled and is now ready for shipment to the 100 MW renewable energy Bit5ive LLC (“Bit5ive”) cryptocurrency mining project based in Pennsylvania.

“The job now is about bringing in revenues from participation in the Bit5ive Pennsylvania project while simultaneously building a track record for the Proceso, Pod5ive Data Center Pods as a global best-in-class solution for mining facilities around the world,” remarked Alonzo Pierce, President and Chairman of ISW Holdings. “We have begun sourcing partnerships in this endeavor, and we feel our technology division has an extremely bright future ahead in step with the growing success of Bitcoin and the broader cryptocurrency space.”

As discussed in prior communications, the Company formed a partnership with Bit5ive in May to build and deliver the single most elegant, powerful, and efficient data center pods in the world. Geared primarily for the cryptocurrency mining industry, the Proceso Pod5ive Data Center offers next-generation dynamic self-management functionality, plug-and-play operation, virtually non-existent maintenance needs, and an industry best-in-class 1.06 Power Usage Effectiveness (“PUE”) score.

Management notes that recent strength in cryptocurrency pricing stands to directly drive demand for cryptocurrency mining equipment as well as the profitability of mining operations. Following Paypal’s landmark announcement to begin accepting and transacting in cryptocurrencies in October, the value of Bitcoin has risen over 33%, opening up more profit potential for highly efficient mining ventures.

The Company continues to anticipate strong performance for the three months ended December 31, 2020, following another breakout quarter during the three months ended September 30, 2020, which set new record high revenues for the Company, driven primarily by continued growth in its Home Healthcare and Telehealth segment – the third consecutive quarter featuring breakout growth for ISW Holdings this year. 

Pierce added, “We are confident in the stability and growth we see from our Home/Telehealth operations, but our overall performance data can swell dramatically with strong execution from our Cryptocurrency Mining and Mining Equipment segment in the months ahead given the timing of our investments in this space and the tailwinds that have come together to define a very productive context.”

About ISW Holdings

ISW Holdings, Inc. (ISWH), based in Nevada, is a diversified portfolio company comprised of essential business lines that serve consumer product demands. Our expertise lies in strategic brand development, early growth facilitation, as well as brand identity through our proprietary procurement process. Together, with our partners, we seek to provide a structure that meets large scalability demands, as well as anticipated marketplace needs. We are able to meet these needs through a variety of strategic innovative processes. ISWH is creating and managing brands across a spectrum of disruptive industries. It maneuvers its proprietary companies through critical stages of market development, which includes conceptualization, go-to-market strategies, engineering, product integration, and distribution efficiency. The company has also partnered with a well-known software development and consulting company. 

Forward Looking Statements

This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including “could”, “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential” and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company’s reports filed from time to time with OTC Markets (www.otcmarkets.com).

For more information, visit www.iswholdings.com

Company Contact:

Investor Relations

[email protected]

ASHBURN, Va., Nov. 19, 2020 (GLOBE NEWSWIRE) — Telos® Corporation (“Telos”), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, announced today the upsizing and pricing of its previously announced initial public offering of 14,968,859 shares of common stock at a price of $17.00 per share (the “Offering”). The shares will be listed on the Nasdaq Global Market under the ticker symbol “TLS” beginning on November 19, 2020. The Offering is expected to close November 23, 2020.

Telos intends to use the net proceeds of the Offering for general corporate purposes, to repurchase a non-controlling interest in Telos Identity Management Solutions LLC, retire all outstanding 12% Cumulative Exchangeable Redeemable Preferred Stock, and repay its outstanding senior term loan and subordinated debt.

B. Riley Securities, BMO Capital Markets, and Needham & Company are acting as joint bookrunners for the Offering. Colliers Securities LLC, D.A. Davidson & Co., Northland Capital Markets, Wedbush Securities, and MKM Partners are serving as co-managers for the Offering. Telos has granted the underwriters a 30-day option to purchase up to an additional 2,245,328 shares of common stock at the initial public offering price, less underwriting discounts and commissions.

A registration statement relating to the Offering was declared effective by the U.S. Securities and Exchange Commission (“SEC”) on November 18, 2020. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The Offering may be made only by means of a prospectus. Copies of the preliminary prospectus relating to the Offering of the shares may be obtained, when available, from B. Riley Securities, Attention: Prospectus Department, 1300 North 17^th Street, Suite 1300, Arlington, VA 22209; telephone: (703) 312-9580, or by emailing [email protected]

Forward-Looking Statements
This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Telos, including those set forth in the Risk Factors section of Telos’ registration statement for the initial public offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Telos undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

About Telos Corporation

Telos Corporation empowers and protects the world’s most security-conscious organizations with solutions for continuous security assurance of individuals, systems, and information. Telos’ offerings include cybersecurity solutions for IT risk management and information security; cloud security solutions to protect cloud-based assets and enable continuous compliance with industry and government security standards; and enterprise security solutions to ensure that personnel can work and collaborate securely and productively. The company serves military, intelligence and civilian agencies of the federal government, allied nations and commercial organizations around the world.

Media:

Kim Hughes
The Blueshirt Group
[email protected]

Investors:

Brinlea Johnson
The Blueshirt Group
[email protected]

SINGAPORE, Nov. 19, 2020 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced Dr Carl Firth, Chief Executive Officer of the company, will participate in a fireside chat at the Piper Sandler 32^nd Annual Virtual Healthcare Conference being held from 30 November to 3 December 2020.

A replay of the pre-recorded fireside chat will be available from November 23, 2020 in the Investor Relations section of ASLAN’s website at www.aslanpharma.com. The replay will be available for 30 days. ASLAN will be participating in 1×1 meetings on 30 November to 3 December 2020, meetings may be requested exclusively via Piper Sandler.

M
edia
and IR
contacts

Emma Thompson Spurwing Communications Tel: +65 6751 2021 Email: [email protected]	Robert Uhl Westwicke Partners Tel: +1 858 356 5932 Email: [email protected]

About ASLAN Pharmaceuticals

ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. Led by a senior management team with extensive experience in global development and commercialisation, ASLAN has a clinical portfolio comprised of a first-in-class monoclonal therapy, ASLAN004, that is being developed in atopic dermatitis and other immunology indications, and ASLAN003, which it plans to develop for autoimmune disease. For additional information please visit www.aslanpharma.com.

Forward
l
ooking
s
tatements

This release and the accompanying financial information, if any, contains forward-looking statements. These statements are based on the current beliefs and expectations of the management of ASLAN Pharmaceuticals Limited and/or its affiliates (the “Company”). These forward-looking statements may include, but are not limited to, statements regarding the Company’s business strategy and clinical development plans; the Company’s plans to develop and commercialise ASLAN004 and ASLAN003; the safety and efficacy of ASLAN004 and ASLAN003; the Company’s plans and expected timing with respect to clinical trials and clinical trial results for ASLAN004 and ASLAN003; the potential for ASLAN004 to deliver a best-in-disease treatment for people with atopic dermatitis; the potential for ASLAN003 to have a best in class profile as a potent oral DHODH inhibitor targeting autoimmune indications; the potential for ASLAN003 to be a treatment for COVID-19 and other viral infections; and the scale of the unmet need in atopic dermatitis. The Company’s estimates, projections and other forward-looking statements are based on management’s current assumptions and expectations of future events and trends, which affect or may affect the Company’s business, strategy, operations or financial performance, and inherently involve significant known and unknown risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of many risks and uncertainties, which include, unexpected safety or efficacy data observed during preclinical or clinical studies; clinical site activation rates or clinical trial enrolment rates that are lower than expected; the impact of the COVID-19 pandemic on the Company’s business and the global economy; general market conditions; changes in the competitive landscape; and the Company’s ability to obtain sufficient financing to fund its strategic and clinical development plans. Other factors that may cause actual results to differ from those expressed or implied in such forward-looking statements are described in the Company’s US Securities and Exchange Commission filings and reports (Commission File No. 001-38475), including the Company’s Annual Report on Form 20-F filed with the US Securities and Exchange Commission on April 16, 2020.  

All statements other than statements of historical fact are forward-looking statements. The words “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan,” or the negative of those terms, and similar expressions that convey uncertainty of future events or outcomes are intended to identify estimates, projections and other forward-looking statements. Estimates, projections and other forward-looking statements speak only as of the date they were made, and, except to the extent required by law, the Company undertakes no obligation to update or review any estimate, projection or forward-looking statement.